ADMINISTRATIVE AND OUTREACH CORE: ABSTRACT The PANUC Administrative and Outreach (Admin) Core has overall responsibility for scientific direction and leadership of our integrated and collaborative multi-site and multidisciplinary center of excellence for research, training and outreach. The Center Director and Administrator, in full collaboration with the Advisory Committees and Executive Committee, coordinate and integrate PANUC components, activities, and resources in pursuit of solutions for our theme of cognitive impairment in PD. Our Admin Core innovates by seamlessly interacting with all major PD-focused research, clinical, outreach, and education efforts in the Pacific Northwest: PANUC, PD Biomarker Program (U01 NS082137), Northwest PD Research Education and Clinical Center (PADRECC), Parkinson's Center of OR, Parkinson's Genetic Research (PaGeR), UW Medicine Memory & Brain Wellness Clinic, and the WA PD Registry. The Admin Core actively supports PANUC's mission to train the next generation of PD researchers by promoting the academic careers of trainees and junior faculty, as well as focusing established investigators on solutions for cognitive impairment in PD. It promotes productive interactions with local, national, and international investigators and research programs focused on PD as part of PANUC's goal to be an effective point of information for investigators and the general public. In addition, the Admin Core ensures that all PANUC investigators and trainees are knowledgeable and fully compliant with human subject, scientific integrity, and NIH, university, VA, and State of Washington or Oregon conduct of scientific research policy requirements.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS062684-07
Application #
9015039
Study Section
Special Emphasis Panel (ZNS1-SRB-J (09))
Project Start
Project End
2016-04-30
Budget Start
2015-09-30
Budget End
2016-06-30
Support Year
7
Fiscal Year
2015
Total Cost
$153,130
Indirect Cost
$54,017
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Flanagan, Margaret E; Cholerton, Brenna; Latimer, Caitlin S et al. (2018) TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study. J Alzheimers Dis 66:1549-1558
Gray, Shelly L; Anderson, Melissa L; Hanlon, Joseph T et al. (2018) Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort. J Alzheimers Dis 65:607-616
Moreno, Monica A; Or-Geva, Noga; Aftab, Blake T et al. (2018) Molecular signature of Epstein-Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflamm 5:e466
Condello, Carlo; Lemmin, Thomas; Stöhr, Jan et al. (2018) Structural heterogeneity and intersubject variability of A? in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci U S A 115:E782-E791
Locke, Timothy M; Soden, Marta E; Miller, Samara M et al. (2018) Dopamine D1 Receptor-Positive Neurons in the Lateral Nucleus of the Cerebellum Contribute to Cognitive Behavior. Biol Psychiatry 84:401-412
Cholerton, Brenna; Johnson, Catherine O; Fish, Brian et al. (2018) Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism Relat Disord 50:29-36
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Houser, Madelyn C; Chang, Jianjun; Factor, Stewart A et al. (2018) Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease. Mov Disord 33:793-804
Hendershott, Taylor R; Zhu, Delphine; Llanes, Seoni et al. (2017) Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease. Parkinsonism Relat Disord 38:31-34
Hill-Burns, Erin M; Debelius, Justine W; Morton, James T et al. (2017) Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord 32:739-749

Showing the most recent 10 out of 178 publications